Diagnostic accuracy and clinical role of rapid C-reactive protein testing in hiv-infected individuals with presumed tuberculosis in south africa

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 1, 2014, Pages 20-26

  Drain, Paul K ^a   Mayeza, L ^b   Bartman, P ^b   Hurtado, R ^a   Moodley, P ^b   Varghese, S ^c   Maartens, G ^d   Alvarez, G G ^b   Wilson, D ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

C reactive protein; Diagnostic testing; HIV AIDS; Point of care test; South Africa; Tuberculosis

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ACID FAST BACTERIUM; ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NURSE; PHYSICIAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; RAPID TEST; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; BLOOD; EVALUATION STUDY; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, PULMONARY;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; COINFECTION; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84892574559     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0519     Document Type: Article

References (35)

1. World Health Organization. Global TB report 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
2. World Health Organization. Joint TB/HIV interventions. Geneva, Switzerland: WHO, 2009.
3. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infectionor AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369: 2042-2049.
4. World Health Organization. Guidelines for intensifi ed tuberculosis case-fi nding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2011.
5. Wallis R S, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-1937.
6. Lawn S D, Edwards D J, Kranzer K, Vogt M, Bekker L G, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009; 23: 1875- 1880.
7. Bassett I V, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010; 51: 823-829.
8. Hassim S, Shaw P A, Sangweni P, et al. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clin Infect Dis 2010; 50: 1053-1059.
9. Saito S, Howard A A, Reid M J, et al. TB diagnostic capacity in sub-Saharan African health care settings. J Acquir Immune Defi c Syndr 2012; 61: 216-220.
10. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
11. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicenter implementation study. Lancet 2011; 377: 1495-1505.
12. Lawn S D, Brooks S V, Kranzer K, et al. Screening for HIVa ssociated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: A prospective study. PLoS Med 2011; 8: e1001067.
13. Drain P K, Losina E, Coleman S M, et al. A prospective, clinicbased study of a urine lipoarabinomannan (LAM) test for pulmonary or extra-pulmonary TB among HIV-infected adults in South Africa. Presentation at the 20th Conference on Retroviruses and Opportunistic Infections, 3-6 March 2013, Atlanta, GA, USA. [Abstract #S-157]
14. Lawn S D, Kerkhoff A D, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: A descriptive study. Lancet Infect Dis 2012; 12: 201- 209.
15. Keeler E, Perkins M D, Small P, et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 2006; 444 (Suppl 1): 49-57.
16. Lawn S D, Wiktor S, Coulibaly D, Ackah A N, Lal R B. Serum C-reactive protein and detection of tuberculosis in persons coinfected with the human immunodefi ciency virus. Trans R Soc Trop Med Hyg 2001; 95: 41-42.
17. Schleicher G K, Herbert V, Brink A, et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 2005; 25: 688-692.
18. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G. Diagnosing smear-negative tuberculosis using case defi nitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 2006; 10: 31-38.
19. Choi C-M, Kang C-I, Jeung W-K, Kim D-H, Lee C-H, Yim J-J. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Tuberc Lung Dis 2007; 11: 233-236.
20. Department of Health, Republic of South Africa. Clinical guidelines for the management of HIV and AIDS in adults and adolescents. Pretoria, South Africa: National Department of Health, South Africa, 2010.
21. The Italian Cooperation in South Africa. Demographic and health indicators KwaZulu-Natal. http://italcoop.co.za/PublicDocuments/Demographic- Health-Statisticaldata-KW-EC-SA%20-EN.pdf Accessed October 2013.
22. Meintjes G, Maartens G, Boulle A, et al. Guidelines for antiretroviral therapy in adults. S Afr J HIV Med 2012; 13: 114- 133.
23. De B K, Smith L G, Owen W E, Roberts W L. Performance characteristics of an automated high-sensitivity C-reactive protein assay on the Dimension RXL analyzer. Clinica Chemica Acta 2002; 323: 151-155.
24. Zecca E, Barone G, Corsello M, et al. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin Chem Lab Med 2009; 47: 1081-1084.
25. Cohen R, Romain O, Lévy C, Perreaux F, Decobert M, et al. Impact of CRP rapid test in management of febrile children in paediatric emergency units of Ile-de-France. Arch Pediatr 2006; 13: 1566-1571.
26. Breen R A M, Leonard O, Perrin F M R, et al. How good are systemic symptoms and blood infl ammatory markers at detecting individuals with tuberculosis? Int J Tuberc Lung Dis 2008; 12: 44-49.
27. Wilson D, Badri M, Maartens G. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLOS ONE 2011; 6: e15248.
28. Lawn S D, Kerkhoff A D, Vogt M, Wood R. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis 2013; 17: 636-643.
29. Alvarez G G, Sabri E, Ling D, Cameron D W, Maartens G, Wilson D. A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. Int J Tuberc Lung Dis 2012; 16: 1247-1251.
30. Diar H A, Nakwa F L, Thomas R, Libhaber E N, Velaphi S. Evaluating the QuikRead C-reactive protein test as a point-ofcare test. Paediatr Int Child Health 2012; 32: 35-42.
31. Siebenhaar R, Mushholt P B, Forst T, et al. Laboratory evaluation of a new lateral-fl ow-based point-of-care rapid test for assessment of chronic systemic infl ammation. J Diabetes Science Technol 2010; 4: 717-722.
32. Grutzmeier S, Sandstrom E. C-reactive protein levels in HIV complicated by opportunistic infections and infections with common bacterial pathogens. Scand J Infect Dis 1999; 31: 229-234.
33. Drain P K, Kupka R, Msamanga G I, Urassa W, Mugusi F, Fawzi W W. C-reactive protein independently predicts HIV disease progression and mortality among women and children in a resource-poor setting. AIDS 2007; 21: 2067-2075.
34. Engel M F, Paling F P, Hoepelman A I M, van der Meer V, Oosterheert J J. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: A systematic review. Family Practice 2012; 29: 383-393.
35. Lawn S D, Harries A D, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908.